Primary Lateral Sclerosis

Neurologic Clinics

Volumn 33, Issue 4, 2015, Pages 749-760

  Statland, Jeffrey M ^a   Barohn, Richard J ^a   Dimachkie, Mazen M ^a   Floeter, Mary Kay ^b   Mitsumoto, Hiroshi ^c  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c NewYork Presbyterian Hospital   (United States)

Author keywords

Motor neuron disease; Neuroimaging; Primary lateral sclerosis; Pseudobulbar affect; Spastic quadriparesis; Upper motor neuron disease

Indexed keywords

AUTOPSY; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DISEASE COURSE; ELECTROMYOGRAPHY; GENETIC ASSOCIATION; HUMAN; PATHOPHYSIOLOGY; PERONEUS NERVE PARALYSIS; PRIMARY LATERAL SCLEROSIS; PRIORITY JOURNAL; PROGNOSIS; PYRAMIDAL TRACT; REVIEW; SYMPTOM ASSESSMENT; TREATMENT PLANNING; CASE REPORT; DIFFERENTIAL DIAGNOSIS; FEMALE; MIDDLE AGED; MOTOR NEURON DISEASE; NEUROIMAGING; SEVERITY OF ILLNESS INDEX;

DIAGNOSIS, DIFFERENTIAL; ELECTROMYOGRAPHY; FEMALE; HUMANS; MIDDLE AGED; MOTOR NEURON DISEASE; NEUROIMAGING; SEVERITY OF ILLNESS INDEX;

EID: 84946484576     PISSN: 07338619     EISSN: 15579875     Source Type: Journal    
DOI: 10.1016/j.ncl.2015.07.007     Document Type: Review

References (48)

1. Le Forestier N., Maisonobe T., Piquard A., et al. Does primary lateral sclerosis exist? A study of 20 patients and a review of the literature. Brain 2001, 124(Pt 10):1989-1999.
2. Singer M.A., Kojan S., Barohn R.J., et al. Primary lateral sclerosis: clinical and laboratory features in 25 patients. J Clin Neuromuscul Dis 2005, 7(1):1-9.
3. Pringle C.E., Hudson A.J., Munoz D.G., et al. Primary lateral sclerosis. Clinical features, neuropathology and diagnostic criteria. Brain 1992, 115(Pt 2):495-520.
4. Singer M.A., Statland J.M., Wolfe G.I., et al. Primary lateral sclerosis. Muscle Nerve 2007, 35(3):291-302.
5. Erb W. Concerning spastic and syphilitic spinal paralysis. Br Med J 1902, 2(2180):1114-1119.
6. Tartaglia M.C., Rowe A., Findlater K., et al. Differentiation between primary lateral sclerosis and amyotrophic lateral sclerosis: examination of symptoms and signs at disease onset and during follow-up. Arch Neurol 2007, 64(2):232-236.
7. Kuipers-Upmeijer J., de Jager A.E., Hew J.M., et al. Primary lateral sclerosis: clinical, neurophysiological, and magnetic resonance findings. J Neurol Neurosurg Psychiatry 2001, 71(5):615-620.
8. Caselli R.J., Smith B.E., Osborne D. Primary lateral sclerosis: a neuropsychological study. Neurology 1995, 45(11):2005-2009.
9. de Koning I., van Doorn P.A., van Dongen H.R. Slowly progressive isolated dysarthria: longitudinal course, speech features, and neuropsychological deficits. J Neurol 1997, 244(10):664-666.
10. Zhai P., Pagan F., Statland J., et al. Primary lateral sclerosis: A heterogeneous disorder composed of different subtypes?. Neurology 2003, 60(8):1258-1265.
11. Floeter M.K., Mills R. Progression in primary lateral sclerosis: a prospective analysis. Amyotroph Lateral Scler 2009, 10(5-6):339-346.
12. Mitsumoto H., Nagy P., Gennings C., et al. Phenotypic and molecular analyses of primary lateral sclerosis. Neurol Genet 2015, 1:e3.
13. Brown W.F., Ebers G.C., Hudson A.J., et al. Motor-evoked responses in primary lateral sclerosis. Muscle Nerve 1992, 15(5):626-629.
14. Gordon P.H., Cheng B., Katz I.B., et al. The natural history of primary lateral sclerosis. Neurology 2006, 66(5):647-653.
15. Peretti-Viton P., Azulay J.P., Trefouret S., et al. MRI of the intracranial corticospinal tracts in amyotrophic and primary lateral sclerosis. Neuroradiology 1999, 41(10):744-749.
16. Kwan J.Y., Jeong S.Y., Van Gelderen P., et al. Iron accumulation in deep cortical layers accounts for MRI signal abnormalities in ALS: correlating 7 Tesla MRI and pathology. PLoS One 2012, 7(4):e35241.
17. Tartaglia M.C., Laluz V., Rowe A., et al. Brain atrophy in primary lateral sclerosis. Neurology 2009, 72(14):1236-1241.
18. Kwan J.Y., Meoded A., Danielian L.E., et al. Structural imaging differences and longitudinal changes in primary lateral sclerosis and amyotrophic lateral sclerosis. Neuroimage Clin 2012, 2:151-160.
19. Butman J.A., Floeter M.K. Decreased thickness of primary motor cortex in primary lateral sclerosis. AJNR Am J Neuroradiol 2007, 28(1):87-91.
20. Claassen D.O., Josephs K.A., Peller P.J. The stripe of primary lateral sclerosis: focal primary motor cortex hypometabolism seen on fluorodeoxyglucose F18 positron emission tomography. Arch Neurol 2010, 67(1):122-125.
21. Chan S., Shungu D.C., Douglas-Akinwande A., et al. Motor neuron diseases: comparison of single-voxel proton MR spectroscopy of the motor cortex with MR imaging of the brain. Radiology 1999, 212(3):763-769.
22. Mitsumoto H., Ulug A.M., Pullman S.L., et al. Quantitative objective markers for upper and lower motor neuron dysfunction in ALS. Neurology 2007, 68(17):1402-1410.
23. Turner M.R., Hammers A., Al-Chalabi A., et al. Cortical involvement in four cases of primary lateral sclerosis using [(11)C]-flumazenil PET. J Neurol 2007, 254(8):1033-1036.
24. Ciccarelli O., Behrens T.E., Johansen-Berg H., et al. Investigation of white matter pathology in ALS and PLS using tract-based spatial statistics. Hum Brain Mapp 2009, 30(2):615-624.
25. Iwata N.K., Kwan J.Y., Danielian L.E., et al. White matter alterations differ in primary lateral sclerosis and amyotrophic lateral sclerosis. Brain 2011, 134(Pt 9):2642-2655.
26. Muller H.P., Unrath A., Huppertz H.J., et al. Neuroanatomical patterns of cerebral white matter involvement in different motor neuron diseases as studied by diffusion tensor imaging analysis. Amyotroph Lateral Scler 2012, 13(3):254-264.
27. Tzarouchi L.C., Kyritsis A.P., Giannopoulos S., et al. Voxel-based diffusion tensor imaging detects pyramidal tract degeneration in primary lateral sclerosis. Br J Radiol 2011, 84(997):78-80.
28. Unrath A., Muller H.P., Riecker A., et al. Whole brain-based analysis of regional white matter tract alterations in rare motor neuron diseases by diffusion tensor imaging. Hum Brain Mapp 2010, 31:1727-1740.
29. van der Graaff M.M., Sage C.A., Caan M.W., et al. Upper and extra-motoneuron involvement in early motoneuron disease: a diffusion tensor imaging study. Brain 2011, 134(Pt 4):1211-1228.
30. Canu E., Agosta F., Galantucci S., et al. Extramotor damage is associated with cognition in primary lateral sclerosis patients. PLoS One 2013, 8(12):e82017.
31. Meoded A., Kwan J.Y., Peters T.L., et al. Imaging findings associated with cognitive performance in primary lateral sclerosis and amyotrophic lateral sclerosis. Dement Geriatr Cogn Dis Extra 2013, 3(1):233-250.
32. Kolind S., Sharma R., Knight S., et al. Myelin imaging in amyotrophic and primary lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 2013, 14(7-8):562-573.
33. Craciun L., Floeter M.K. Motor unit number estimation in primary lateral sclerosis. Muscle and Nerve 2009, 40(4):710.
34. de Carvalho M., Turkman A., Swash M. Motor unit firing in amyotrophic lateral sclerosis and other upper and lower motor neurone disorders. Clin Neurophysiol 2012, 123(11):2312-2318.
35. Floeter M.K., Zhai P., Saigal R., et al. Motor neuron firing dysfunction in spastic patients with primary lateral sclerosis. J Neurophysiol 2005, 94(2):919-927.
36. Geevasinga N., Menon P., Sue C.M., et al. Cortical excitability changes distinguish the motor neuron disease phenotypes from hereditary spastic paraplegia. Eur J Neurol 2015, 22(5):826-831.
37. Weber M., Stewart H., Hirota N., et al. Corticomotoneuronal connections in primary lateral sclerosis (PLS). Amyotroph Lateral Scler Other Motor Neuron Disord 2002, 3(4):190-198.
38. Fisher K.M., Zaaimi B., Williams T.L., et al. Beta-band intermuscular coherence: a novel biomarker of upper motor neuron dysfunction in motor neuron disease. Brain 2012, 135(Pt 9):2849-2864.
39. Bai O., Vorbach S., Hallett M., et al. Movement-related cortical potentials in primary lateral sclerosis. Ann Neurol 2006, 59(4):682-690.
40. Agosta F., Canu E., Inuggi A., et al. Resting state functional connectivity alterations in primary lateral sclerosis. Neurobiol Aging 2014, 35(4):916-925.
41. Meoded A., Morrissette A.E., Katipally R., et al. Cerebro-cerebellar connectivity is increased in primary lateral sclerosis. Neuroimage Clin 2015, 7:288-296.
42. Fink J.K. Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms. Acta Neuropathol 2013, 126(3):307-328.
43. Rowland L.P. Primary lateral sclerosis, hereditary spastic paraplegia, and mutations in the alsin gene: historical background for the first International Conference. Amyotroph Lateral Scler Other Motor Neuron Disord 2005, 6(2):67-76.
44. van Rheenen W., van Blitterswijk M., Huisman M.H., et al. Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseases. Neurology 2012, 79(9):878-882.
45. Gordon P.H., Cheng B., Katz I.B., et al. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS. Neurology 2009, 72(22):1948-1952.
46. Bruyn R.P., Koelman J.H., Troost D., et al. Motor neuron disease (amyotrophic lateral sclerosis) arising from longstanding primary lateral sclerosis. J Neurol Neurosurg Psychiatry 1995, 58(6):742-744.
47. Jackson C.E., Gronseth G., Rosenfeld J., et al. Randomized double-blind study of botulinum toxin type B for sialorrhea in ALS patients. Muscle Nerve 2009, 39(2):137-143.
48. Symptom Management and End of Life Care, in press.